Sudden death and associated factors in a historical cohort of chronic haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2529-2536

  Genovesi, Simonetta ^a,b   Valsecchi, Maria G ^a   Rossi, Emanuela ^a   Pogliani, Daniela ^a   Acquistapace, Irene ^a   De Cristofaro, Vincenzo ^c   Stella, Andrea ^a,b   Vincenti, Antonio ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c Sondrio Hospital   (Italy)

Author keywords

Atrial fibrillation; Diabetes; Haemodialysis; Hyperkalaemia; Sudden death

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; DIABETES MELLITUS; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; HYPERKALEMIA; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CAUSE OF DEATH; DEATH, SUDDEN; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERKALEMIA; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 67651115710     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp104     Document Type: Article

References (28)

1. U.S. Renal Data System, URDS 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
2. Priori SG, Aliot E, Blomstrom-Lundqvist C et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001; 22: 1374-450
3. Bleyer AJ, Hartman J, Brannon PC et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006; 69: 2268-2273
4. Paoletti E, Specchia C, Di Maio G et al. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 years survey. Nephrol Dial Transplant 2004; 19: 1829-1834
5. Parekh RS, Plantiga LC, Kao WHL et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 2008; 74: 1335-1342
6. Karnik JA, Young BS, Lew NL et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350-357
7. Genovesi S, Vincenti A, Rossi E et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008; 51: 255-262
8. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902
9. Foley RN, Parfrey PS, Harnett JD et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192
10. Benjamin EJ, Wolf PA, D'Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952
11. Wang TJ, Larson MG, Levy D et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. The Framingham Heart Study. Circulation 2003; 107: 2920-2925
12. Jouven X, Desnos M, Guerot C et al. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study. I. Eur Heart J 1999; 20: 896-899
13. Bigger JT Jr, Fleiss JL, Kleiger R et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250-258
14. Solomon SD, Anavekar N, Skali H et al. Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators: influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005; 112: 3738-3744
15. Solomon SD, Zelenkofske S, McMurray JJV et al. Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients withmyocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581-2588
16. Genovesi S, Dossi C, Viganò MR et al. Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace 2008; 10: 771-777
17. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-1299
18. Kjiellstrand CM, Buoncristiani U, Ting G et al. Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 2008; 23: 3283-3289
19. Moss AJ, Hall WJ, Cannom DS et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940
20. Moss AJ, Zareba W, Hall WJ et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantantion of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883
21. Bardy GH, Lee KL, Mark DB et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Sudden Cardiac Death-Heart Failure Trial Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237
22. Herzog CA, Li S, Weinhandl ED et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68: 818-825
23. Wase A, Basit A, Nazir R et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004; 11: 199-204
24. Robin J, Weinberg K, Tiongson J et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006; 3:1196-1201
25. Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverterdefibrillator recipients. Pacing Clin Electrophysiol 2007; 30: 1091-1105
26. Dasgupta A, Montalvo J, Medendorp S et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007; 49: 656-663
27. Burke AP, Tracy RP, Kolodgie FK et al. Elevated C-Reactive Protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105: 2019-2023
28. Albert CM, Ma J, Rifai N et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595-2599